Literature DB >> 27866076

Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model.

Laura Braud1, Sylvain Battault2, Grégory Meyer2, Alessandro Nascimento2, Sandrine Gaillard3, Georges de Sousa4, Roger Rahmani4, Catherine Riva2, Martine Armand5, Jean-Michel Maixent6, Cyril Reboul2.   

Abstract

Oxidative stress could trigger lipid accumulation in liver and thus hepatic steatosis. Tea is able to prevent liver disorders, but a direct link between antioxidant capacities and prevention of steatosis has not been reported yet. We aimed to investigate such relationship in a rat model of high fat-high sucrose diet (HFS)-induced obesity and to explore more deeply the mechanisms in isolated hepatocytes. Wistar rats were divided into a control group (standard diet), an HFS group (high fat-sucrose diet) and an HFS+tea group (HFS diet with ad-libitum access to tea drink). Body weight, fat mass, glycemic parameters in blood, lipid and oxidative stress parameters in blood and liver were measured in each group after 14 weeks. Isolated hepatocytes were treated with the reactive oxygen species (ROS) inducer t-BHP in the presence or not of antioxidants (tempol or tea), and superoxide anion production and lipid accumulation were measured using specific fluorescent probes. We reported that the HFS diet highly increased hepatic lipids content, while tea consumption attenuated steatosis and improved the oxidative status (decrease in hepatic oxidative stress, increase in plasma total antioxidant capacity). The role of antioxidant properties of tea in such phenomenon was confirmed in primary cultured rat hepatocytes. Indeed, the increase of mitochondrial ROS production with t-BHP resulted in lipid accumulation in hepatocytes (positive linear regression), and antioxidants (tempol or tea) normalized both. We reported that the antioxidant properties of tea protect rats from an obesogenic HFS diet-induced hepatic steatosis by counteracting the ROS-dependent lipogenesis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antilipogenesis; Antioxidant; Camellia sinensis; Mitochondrial ROS; NAFLD; Obesogenic diet

Mesh:

Substances:

Year:  2016        PMID: 27866076     DOI: 10.1016/j.jnutbio.2016.10.012

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  10 in total

1.  Anti-obesity Effects of Dark Tea Extracts by Down-regulation of C/EBPα and PPARγ.

Authors:  Hyeong-Joon Lim; Taek Joo Lim; Jin Hyun Lee; Jun Hee Lee; Myeong-Ok Kim; Ji Yun Park; Jong-Tae Kim; Min-Jeong Kim; Seong-Hee Jang; Seok Hwa Choi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  Monkfish Peptides Mitigate High Fat Diet-Induced Hepatic Steatosis in Mice.

Authors:  Jiena Ye; Xiaoxiao Tian; Qiongfen Wang; Jiawen Zheng; Yanzhuo Yang; Baogui Xu; Shuai Zhang; Falei Yuan; Zuisu Yang
Journal:  Mar Drugs       Date:  2022-05-05       Impact factor: 6.085

Review 3.  Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application.

Authors:  Hang-Yu Li; Ren-You Gan; Ao Shang; Qian-Qian Mao; Quan-Cai Sun; Ding-Tao Wu; Fang Geng; Xiao-Qin He; Hua-Bin Li
Journal:  Oxid Med Cell Longev       Date:  2021-03-01       Impact factor: 6.543

4.  Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.

Authors:  Fangfang Huang; Jiajia Wang; Fangmiao Yu; Yunping Tang; Guofang Ding; Zuisu Yang; Yu Sun
Journal:  Mar Drugs       Date:  2018-01-23       Impact factor: 5.118

Review 5.  Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review.

Authors:  Guo-Yi Tang; Xiao Meng; Ren-You Gan; Cai-Ning Zhao; Qing Liu; Yi-Bin Feng; Sha Li; Xin-Lin Wei; Atanas G Atanasov; Harold Corke; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2019-12-08       Impact factor: 5.923

6.  Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease.

Authors:  Guangyu Jiang; Dayin Chen; Wenpeng Li; Chengcheng Liu; Jiguang Liu; Yingxue Guo
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

7.  Anti-Apoptotic Effect of Flavokawain A on Ochratoxin-A-Induced Endothelial Cell Injury by Attenuation of Oxidative Stress via PI3K/AKT-Mediated Nrf2 Signaling Cascade.

Authors:  Peramaiyan Rajendran; Abdullah M Alzahrani; Vishnu Priya Veeraraghavan; Emad A Ahmed
Journal:  Toxins (Basel)       Date:  2021-10-21       Impact factor: 4.546

8.  Synergistic delivery of resveratrol and ultrasmall copper-based nanoparticles by aptamer-functionalized ultrasound nanobubbles for the treatment of nonalcoholic fatty liver disease.

Authors:  Xinmin Guo; Zhihui Huang; Jialin Chen; Kun He; Jianru Lin; Hui Zhang; Yanying Zeng
Journal:  Front Physiol       Date:  2022-09-09       Impact factor: 4.755

9.  Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease.

Authors:  Meiqi Fan; Young-Jin Choi; Yujiao Tang; Sung Mun Bae; Hyun Pil Yang; Eun-Kyung Kim
Journal:  Nutrients       Date:  2019-10-27       Impact factor: 5.717

10.  The Alterations of Mitochondrial Function during NAFLD Progression-An Independent Effect of Mitochondrial ROS Production.

Authors:  Inês C M Simões; Ricardo Amorim; José Teixeira; Agnieszka Karkucinska-Wieckowska; Adriana Carvalho; Susana P Pereira; Rui F Simões; Sylwia Szymanska; Michał Dąbrowski; Justyna Janikiewicz; Agnieszka Dobrzyń; Paulo J Oliveira; Yaiza Potes; Mariusz R Wieckowski
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.